Dose-adjusted Adjuvant FEC Compared to Standard FEC for Breast Cancer

NCT03888677 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1535

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: 5-FU, epirubicin and cyclophosphamide

Sponsor

Henrik Lindman

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]